We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
Sensus Healthcare, Inc. (SRTS - Free Report) closed the most recent trading day at $3.29, moving +2.17% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.31%, and the technology-dominated Nasdaq saw an increase of 0.89%.
Coming into today, shares of the company had gained 1.9% in the past month. In that same time, the Medical sector gained 3.7%, while the S&P 500 gained 0.16%.
Market participants will be closely following the financial results of Sensus Healthcare, Inc. in its upcoming release. In that report, analysts expect Sensus Healthcare, Inc. to post earnings of -$0.12 per share. This would mark a year-over-year decline of 271.43%. At the same time, our most recent consensus estimate is projecting a revenue of $4.64 million, reflecting a 47.51% fall from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of -$0.43 per share and revenue of $26.34 million. These results would represent year-over-year changes of -204.88% and -37%, respectively.
Any recent changes to analyst estimates for Sensus Healthcare, Inc. should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Sensus Healthcare, Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 91, which puts it in the top 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know
Sensus Healthcare, Inc. (SRTS - Free Report) closed the most recent trading day at $3.29, moving +2.17% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.58%. Meanwhile, the Dow experienced a rise of 0.31%, and the technology-dominated Nasdaq saw an increase of 0.89%.
Coming into today, shares of the company had gained 1.9% in the past month. In that same time, the Medical sector gained 3.7%, while the S&P 500 gained 0.16%.
Market participants will be closely following the financial results of Sensus Healthcare, Inc. in its upcoming release. In that report, analysts expect Sensus Healthcare, Inc. to post earnings of -$0.12 per share. This would mark a year-over-year decline of 271.43%. At the same time, our most recent consensus estimate is projecting a revenue of $4.64 million, reflecting a 47.51% fall from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of -$0.43 per share and revenue of $26.34 million. These results would represent year-over-year changes of -204.88% and -37%, respectively.
Any recent changes to analyst estimates for Sensus Healthcare, Inc. should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Sensus Healthcare, Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 91, which puts it in the top 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.